Stockscreener 앱 받기
1.80
1.12%
0.02
Biodesix Inc 주식(BDSX)의 최신 뉴스
BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle
Biodesix, Inc. (NASDAQ:BDSX) Sees Significant Decrease in Short Interest - Defense World
BD launches new prefillable syringe, expands platform capacity - Drug Delivery Business News
Biodesix (NASDAQ:BDSX) Coverage Initiated at Scotiabank - Defense World
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update - Defense World
Sartorius Stedim Biotech (EPA:DIM) Shares Down 1.3% - Defense World
Despite lower earnings than five years ago, Boyd Group Services (TSE:BYD) investors are up 19% since then - Simply Wall St
Boyd Group Services Announces Q3 Cash Dividend - TipRanks
Biodesix (NASDAQ:BDSX) Now Covered by Scotiabank - MarketBeat
Biodesix initiated with an Outperform at Scotiabank - TipRanks
BeyondSpring (BYSI) Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC - StreetInsider.com
BeyondSpring (BYSI) Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel - StreetInsider.com
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 15.6% in August - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives $3.08 Average PT from Analysts - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Recommendation of “Buy” from Analysts - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Position Boosted by AIGH Capital Management LLC - MarketBeat
Biodesix to Present at Two Investor Conferences in September - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 5.9% in August - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Average Rating of “Buy” by Analysts - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Receives $3.08 Average Target Price from Brokerages - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 11.2% in July - MarketBeat
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024 - GlobeNewswire Inc.
Biodesix CEO Scott Hutton sells shares worth over $5,900 By Investing.com - Investing.com Australia
Biodesix CFO sells over $1,500 in company stock By Investing.com - Investing.com Australia
Biodesix executive sells over $300 in stock, prices range $1.52 to $1.64 - Investing.com Australia
Biodesix exec sells over $680 in stock, automatic sale for taxes - Investing.com Australia
Biodesix CFO sells over $1,500 in company stock - Investing.com India
Biodesix CFO sells over $1,500 in company stock - Investing.com
Biodesix exec sells over $680 in stock, automatic sale for taxes - Investing.com
Biodesix executive sells over $300 in stock, prices range $1.52 to $1.64 - Investing.com Canada
Biodesix CEO Scott Hutton sells shares worth over $5,900 By Investing.com - Investing.com UK
Biodesix, Inc. Expected to Post Q3 2024 Earnings of ($0.08) Per Share (NASDAQ:BDSX) - MarketBeat
Q3 2024 EPS Estimates for Biodesix, Inc. Reduced by William Blair (NASDAQ:BDSX) - Defense World
Biodesix (NASDAQ:BDSX) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Biodesix raises sale guidance after strong second quarter - BizWest
Earnings call: Biodesix reports robust growth and raises 2024 guidance By Investing.com - Investing.com Canada
Earnings call: Biodesix reports robust growth and raises 2024 guidance - Investing.com
Earnings call: Biodesix reports robust growth and raises 2024 guidance By Investing.com - Investing.com India
Earnings call: Biodesix reports robust growth and raises 2024 guidance By Investing.com - Investing.com UK
Biodesix, Inc. (NASDAQ:BDSX) Q2 2024 Earnings Call Transcript - Insider Monkey
Biodesix Inc (BDSX) Q2 2024 Earnings Call Transcript Highlights: - GuruFocus.com
Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript - Seeking Alpha
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Biodesix Announces Second Quarter 2024 Results and Highlights - Business Wire
BDSXBiodesix, Inc. Latest Stock News & Market Updates - StockTitan
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference - Business Wire
Biodesix (BDSX) to Release Quarterly Earnings on Wednesday - Defense World
Biodesix (BDSX) to Release Earnings on Wednesday - MarketBeat
Analysts Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.08 - Defense World
Biodesix (NASDAQ:BDSX) Now Covered by Craig Hallum - Defense World
Biodesix shares receive new Buy rating on company's potential - Investing.com India
Biodesix (NASDAQ:BDSX) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) Price Target at $3.08 - MarketBeat
Biodesix shares receive new Buy rating on company's potential - Investing.com
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 - Business Wire
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 - Yahoo Finance
Biodesix, Inc. (NASDAQ:BDSX) adds US$25m in market cap and insiders have a 50% stake in that gain - Simply Wall St
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Grows By 137.9% - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Sees Large Increase in Short Interest - Defense World
Biodesix (NASDAQ:BDSX) Stock Price Up 1.3% - Defense World
Biodesix (NASDAQ:BDSX) Stock Price Up 1.3% - MarketBeat
Taking on analysts' expectations and winning: Biodesix Inc (BDSX) – Sete News - SETE News
Bioinformatics in IVD Testing Industry Value Chain Analysis| Affymetrix, AssureRx Health Inc., Aperico Technologies Inc ... - Economica
Financial Health Check: Examining Biodesix Inc (BDSX)'s Key Ratios – DWinneX - The Dwinnex
1.06%
0.71%
자본화:
|
볼륨(24시간):